- Home
- SNDX vs CET Comparison
SNDX vs CET Comparison
Compare SNDX & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- CET
- Stock Information
- Founded
- SNDX 2005
- CET 1929
- Country
- SNDX United States
- CET United States
- Employees
- SNDX N/A
- CET N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- CET Finance/Investors Services
- Sector
- SNDX Health Care
- CET Finance
- Exchange
- SNDX Nasdaq
- CET Nasdaq
- Market Cap
- SNDX 1.4B
- CET 1.3B
- IPO Year
- SNDX 2016
- CET N/A
- Fundamental
- Price
- SNDX $13.63
- CET $46.25
- Analyst Decision
- SNDX Strong Buy
- CET
- Analyst Count
- SNDX 11
- CET 0
- Target Price
- SNDX $37.64
- CET N/A
- AVG Volume (30 Days)
- SNDX 1.9M
- CET 33.2K
- Earning Date
- SNDX 11-05-2024
- CET 01-01-0001
- Dividend Yield
- SNDX N/A
- CET 4.97%
- EPS Growth
- SNDX N/A
- CET 64.57
- EPS
- SNDX N/A
- CET 10.32
- Revenue
- SNDX $16,000,000.00
- CET $23,374,777.00
- Revenue This Year
- SNDX N/A
- CET N/A
- Revenue Next Year
- SNDX N/A
- CET N/A
- P/E Ratio
- SNDX N/A
- CET $4.52
- Revenue Growth
- SNDX N/A
- CET 41.71
- 52 Week Low
- SNDX $13.26
- CET $36.89
- 52 Week High
- SNDX $25.34
- CET $49.51
- Technical
- Relative Strength Index (RSI)
- SNDX 30.64
- CET 39.05
- Support Level
- SNDX $13.36
- CET $46.16
- Resistance Level
- SNDX $14.18
- CET $47.52
- Average True Range (ATR)
- SNDX 0.81
- CET 0.44
- MACD
- SNDX -0.18
- CET -0.12
- Stochastic Oscillator
- SNDX 11.32
- CET 3.36
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.